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Purpose: The purpose of this study was to develop abifurcated endoluminal prosthesis for 
transfemoral p acement in the aortoiliac position with a large-animal model that would 
simulate human implantation. 
Methods: Fifteen calves (160 to 200 kg) underwent bilateral femoral artery exposure and 
transfemoral placement in the aortoiliac position of a bifurcated Dacron prosthesis, 
inserted through a 26F sheath with an over-the-bifurcation guide wire to retrieve the 
contralateral limb and secured proximally and distally with self-expanding attachment 
systems. The preferred location was determined before implantation and compared with 
final implant location by caliper measurements and angiography. Events during implan- 
tation, maneuvers used to accomplish accurate deployment, and final results, as judged by 
angiography and clinical evaluation, were recorded. Four animals urvived and were used 
for chronic evaluation and healing by gross and microscopic studies. 
Results: All grafts (n = 15) were patent at the end of the procedure. All (n = 7) 
noncrimped grafts had minor kinks in areas of curvature, whereas eight of eight crimped 
grafts (device modification) had none. Torque control of the body and individual limbs was 
necessary to correct wists before deployment in 10 of 15 grafts, with two greater than 
30-degree twists remaining, which did not appear to affect flow. One implant was entirely 
deployed in the aorta because of parallax error, subsequently avoided by use of a marker 
board placed dorsally. Three premature deployments occurred, corrected by attachment 
system lock modification. The mean final implant position was within 2.9 -+ 1.4 mm 
(aortic), 1.6 - 1.1 mm, and 1.5 -+ 0.8 mm (eontralateral nd ipsilateral iliac limbs, 
respectively) of the intended position. Three of four animals intended for long-term 
evaluation were killed prematurely because of clinically evident spinal cord ischemia. 
Histologic sections at 2 weeks showed early wall repair without inflammatory cells and 
pannus ingrowth across the anastomosis. 
Conclusion: We conclude that implantation of a bifurcated endovascular prosthesis 
through the bilateral femoral approach is possible, provided the intended aortic 
implantation site (neck) is at least 12 mm in length (mean -+ 2 SD each direction). Torque 
control of each portion of the device will be needed in the majority of instances, with 
attention to parallax effect necessary for optimal placement. This animal model is not 
suitable for chronic graft evaluation because of its sensitivity for spinal cord ischemia. 
Healing data suggest graft incorporation similar to that of a surgically placed prosthesis. 
(J VASC SURG 1995;22:370-81.) 
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The incidence of infrarenal abdominal aortic 
aneurysm appears to be on the rise. Surgical repair 
of an infrarenal abdominal aortic aneurysm by 
endoaneurysmorrhaphy is a well-established option 
with durable results and anticipated improved life 
expectancy} 3 Expected perioperative mortality and 
morbidity rates have continued to decrease, likely 
the result of improved surgical technique, invasive 
perioperative monitoring, and attention to impor- 
tant risk factors associated with this lesion. Al- 
though acceptable mortality rates of 2% to 3% can 
be accomplished by most experienced vascular sur- 
geons, the surgical trauma resulting from the com- 
bined laparotomy, aortic occlusion, and length of 
recovery contribute to what is overall a major 
undertaking. Although a retroperitoneal pproach 
has been advocated in reducing perioperative mor- 
bidity rates, randomized trials have failed to docu- 
ment a clear difference. 4,s In addition, because of 
comorbid conditions, a significant number of pa- 
tients do not undergo repair because of prohibitive 
expected perioperative morbidity and mortality 
rates.  
In 1991 an alternative t chnique for graft replace- 
ment was introduced by Parodi et al.6 This involved 
aneurysm exclusion by transluminal implantation of 
a Dacron prosthesis. Enthusiasm for the technique 
has evolved rapidly, with other alternative devices 
developed quickly in phase I clinical trials. In our own 
experience at the University of California, Los 
Angeles, Medical Center with the Endovascular 
Technologies (EVT) endovascular tube graft, excel- 
lent early results have been obtained in the first 16 
patients, with no deaths and morbidity limited to 
successful conversion to a standard surgical approach 
in two patients. 7 The benefits of this approach are 
clearly evident when one considers that all patients 
were discharged within 48 hours of the procedure. 
Nevertheless, shortly after initiation of this phase I
trial, it became vident hat the majority of patients 
were not eligible for tube graft repair by endovascular 
means because of either a lack of a distal neck at the 
aortic bifurcation or the presence of a proximal iliac 
aneurysm that required attention. In all, 57% of 
patients creened for endovascular tube graft repair 
were rejected because of these features. 7 This large 
number of patients would be suitable for an endo- 
vascular bifurcated graft repai r . The purpose of this 
study was to develop and evaluate the performance of
a bifurcated endoluminal prosthesis for transfemoral 
placement in the aortoiliac position, with a large 
animal model that would simulate human implan- 
tation. 
METHOD 
Juvenile bovines weighing between 350 and 400 
pounds were used for this study. The primary reason 
for using this species is that the diameter of the 
femoral arteries, iliac arteries, and aorta in this size 
calf are similar to those encountered in the average- 
sized human. In addition, previous experience with 
the endovascular tube graft suggested that full-scale 
catheters and devices were more useful in evaluating 
performance, compared with studies that used scaled- 
down devices. Each animal was quarantined at the 
testing laboratory for at least 4 days before implan- 
tation. The animal was then fasted for 12 hours 
before implantation and given intramuscular ntibi- 
otics 24 hours before surgery. All methods followed 
the Guide for the Care and Use of Laboratory Animals 
(National Institutes of Health publication No. 86- 
23, revised 1985). 
Fifteen calves, weighing between 350 and 400 
pounds, were anesthetized with intramuscular keta- 
mine, intubated, and mechanically ventilated with a 
mixture of halothane and oxygen. After preparation 
and draping, both common femoral arteries were 
exposed through longitudinal groin incisions. The 
animals were kept in a supine position, with a special 
inflatable device used for support. Heparin was 
administered to achieve an activated clotting time of 
greater than 200 seconds. An introducer sheath was 
then placed into the right femoral artery and an 8F 
pigtail angiographic catheter was passed over a guide 
wire, through the introducer sheath, and into the 
aorta under fluoroscopic guidance. The pigtail cath- 
eter contains a series of platinum bands at precise 
i cm intervals and is used to measure the length of the 
grafted segment and magnification of both the 
fluoroscopic image and subsequent x-ray films. The 
tip of the pigtail catheter was then positioned close to 
the second lumbar vertebra nd contrast agent was 
injected under fluoroscopy to document the position 
of the ventral left renal artery. A single x-ray film was 
obtained uring injection of contrast material with a 
power injector at 35 ml/sec for 11/2 seconds (preim- 
plant angiogram). 
The positions of the renal arteries and the iliac 
bifurcation were identified on the preimplant angio- 
gram (Fig. 1). In addition, the internal diameter of 
the aorta at the intended superior implantation site 
and the diameters of the iliac arteries near the 
intended inferior implantation site were measured 
and recorded. The length of the graft needed for 
implantation to occur below the renal arteries and 
above the takeoff of the lateral circumflex iliac artery 
was then determined by caliper measures corrected 
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Table I. Summary of results 
Final implant (ram) 
Animal no. Graft type )[Gnk Aortic Iliac Contrailiac Remarks 
1 Noncrimped Yes 1.0 1.0 1.6 
2 Noncrimped Yes 4.9 0.7 1.6 
3 Noncrimped Yes 1.8 1.6 1.7 
4 Noncrimped Yes 1.2 N/A N/A 
5 Noncrimped Yes 2.4 0 1.4 
6 Noncrimped Yes 2.5 2.8 1.8 
7 Noncrimped Yes 1.9 2.7 1.5 
8 Crimped No 4.0 2.4 4.7 
9 Crimped No 2.8 1.8 2.1 
10 Crimped No 2.9 1.6 1.5 
11 Crimped No 5.5 1.7 1.4 
12 Crimped No 2.1 0.6 1.9 
13 Crimped No 1.8 0.6 0.7 
14 Crimped No 4.0 0.9 1.1 
15 Crimped No 4.2 1.4 1.1 
Premature deployment contralateral limb, 
30-degree twist 
Device deployed entirely in aorta, parallax error 
Premature deployment contralateral limb 
Premature deployment contralateral limb, 
30-degree twist 
for magnification (usually 20%). The anatomy of the 
calf is somewhat different from that of the human, in 
that the internal iliac arteries come off as a single 
trunk at the aortic bifurcation and then divide to form 
the right and left internal iliac arteries. A large lateral 
circumflex iliac artery takes off approximately 5 cm 
from the aortic bifurcation. It was our intention to 
implant he device between the renal arteries and the 
lateral circumflex iliac takeoff. 
The angiographic catheter is then removed and 
the introducer sheath exchanged over a wire for an 
EVT expandable sheath, specifically manufactured to 
accept he 23F device. A bifurcated EVT device is 
then selected to provide an endograft diameter that is 
slightly greater than the maximum diameter of the 
aorta at the intended implantation site (Fig. 2). The 
following sequence describes in a stepwise fashion 
the technique for deployment. This is illustrated in 
Fig. 3. 
A snare catheter is passed up through the 
contralateral femoral artery until it resides proximal 
to the caudal point of the aortic bifurcation. The 
transfemoral guide wire of the bifurcated evice is 
passed up the ipsilateral femoral artery and captured 
with the contralateral snare. The snare is then pulled 
through the contralateral femoral artery. This trans- 
femoral guide wire is attached to a guiding tube that 
ultimately connects to a capsule that houses the 
contralateral iliac attachment system of the bifurcated 
prosthesis. 
Maintaining slight tension on the transfemoral 
guide wire, the bifurcated evice is introduced and 
advanced into the abdominal aorta over a stiff 
Amplatz 0.035-inch guide wire (Meadox Surgimed, 
Oakland, N.J.). The capsule jacket is then retracted to 
free the legs of the bifurcated prosthesis: The superior 
attachment system is positioned istal to the renal 
arteries, and both iliac attachment systems are 
positioned in the iliac arteries. While manipulating 
the deployment catheter, one can visualize fluoro- 
scopically asystem of radiopaque markers that allow 
identification of twists in the device, in both the body 
and each individual imb. Before implantation, cor- 
rections for implant wists are made to the trunk and 
ipsilateral eg with various features on the main 
deployment catheter. Corrections for twisting in the 
contralateral leg are assisted with a torquing catheter 
that is locked in place over the transfemoral guide 
wire. 
Shortly after initiating the experiment, it became 
evident that because of the size of the animals and the 
distance between the fluoroscopy unit and the aorta 
in the posterior etroperitoneal space, a significant 
degree of parallax error is introduced with slight 
movements of the fluoroscopic unit. For this reason, 
and after a mispositioned implant because of parallax 
error, a marker board was placed posterior to the 
animal to facilitate identification of intended eploy- 
ment site. This marker board has movable markers 
that can be seen fluoroscopically and placed at the 
intended sites of implantation. 
Once the device is in its desired location, the 
superior attachment system is exposed, by the control 
knob in the handle of the catheter. The attachment 
system consists of a self-expanding unit that opposes 
the inner surface of the aortic wall and has attachment 
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hooks in its most proximal portion. The attachment 
hooks are at variable distances from the end of the 
actual prosthesis, with a maximal distance of 0.5 cm. 
The balloon catheter, which is housed within the 
prosthesis, is then unlocked and advanced cephalad 
until the implantation balloon resides within the 
superior attachment system. Inflating the balloon 
firmly drives the hooks of the superior attachment 
system into the aortic wall. While the balloon is 
inflated, which helps to secure the superior attach- 
ment of' the prosthesis, the ipsilateral and contralat- 
eral iliac attachment systems are d ployed. Intermit- 
tent deflation of the proximal balloon allows blood to 
enter the prosthesis with some pressure, and this 
helps in expanding the graft to identify and avoid 
twists. 
While the proximal balloon is inflated, a torque 
catheter is introduced over the contralateral trans- 
femoral guide wire and locked in place to allow 
torque control of the contralateral limb. Once the 
markers are identified in their proper orientation 
(smallest appearance on fluoroscopy), the contralat- 
eral attachment system can be deployed by unlocking 
the unit and advancing a nitinol wire, which secures 
the attachment system within the capsule. The 
capsule is then retracted, releasing the attachment 
system in the contralateral iliac artery. The nitinol 
wire is maintained through the contralateral limb, 
whereas the capsule and torque catheter are removed 
and an appropriate-size angioplasty balloon is intro- 
duced over the nitinol wire. The contralateral attach- 
ment system is then secured in place by inflating the 
angioplasty balloon. Subsequent inflations are per- 
formed within the contralateral limb to make sure 
that it is completely open, without any creases or 
folds. 
The ipsilateral iliac attachment system is then 
examined under fluoroscopy. By freeing the balloon, 
the main catheter can be rotated, providing torque 
control of the ipsilateral limb. Similar to the con- 
tralateral side, lateral location of the markers with the 
smallest profile evident on fluoroscopy indicates the 
absence of twists. Once accomplished, and while 
holding slight tension in the limb, the lock mecha- 
nism is released by pushing the ipsilateral locking 
collar into the ipsilateral limb. This releases the 
ipsilateral limb, allowing retraction of the capsule 
that maintains the attachment system dosed. The 
attachment system is self-expanding and thus, on 
release, is deployed effectively in the iliac artery. The 
aortic balloon may be used as the initial balloon 
dilation of the ipsilateral imb by deflating it, 
retracting it into the limb, and gently inflating it, 
Fig. 1. Preimplant aortogram in calf. Note large trifurca- 
tion system with common internal iliac artery trunk 
(triangles) bifurcating into internal iliac arteries. Circumflex 
iliac arteries noted by curved arrows on both sides and open 
arrow denoting right renal artery. Size measurements were 
made correcting for magnification. 
keeping in mind that it is an oversized balloon for this 
use. Preferably, the entire system is removed, leaving 
the ipsilateral guide wire in place to be used as a 
guiding wire for an angioplasty balloon, which 
dilates the ipsilateral limb, securing the ipsilateral iliac 
attachment system. The angioplasty balloon is re- 
moved and an angiographic catheter is inserted for 
completion angiography (Fig. 4). 
The intended implantation site was determined 
on the preimplant angiogram. The final implant site 
was determined on the completion angiogram, and 
the two were compared by caliper measurements. All 
events during implantation, maneuvers used to 
accomplish accurate deployment, and final results, 
including patency (as judged by angiography and 
clinical evaluation), were recorded. Four of the 15 
animals urvived, with an intent o provide healing 
information by both gross and microscopic studies. 
For chronic studies, the animals were reanesthetized 
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Fig. 2. Schematic diagram of EVT endovascular bifurcated graft deployment catheter. Upper 
ha/f denotes catheter handle with various ports and knobs used during deployment (see text). 
Lower half, joined through main catheter tubing is actual device used for insertion and 
implantation. Note pull-wire assembly, which is connected to contralateral capsule and limb. 
Superior capsule houses proximal attachment system. Bifurcated endograft is housed within 
capsule jacket. 
with intramuscular ketamine, intubated, and me- 
chanically ventilated with a mixture of halothane and 
oxygen. The left side of the neck was prepared, and 
the carotid artery was exposed. An 8F pigtail angio- 
graphic catheter was then passed into the carotid 
artery and over a guide wire into the aorta. The cath- 
eter was then positioned to perform preexplant angi- 
ography. The pigtail catheter was then removed and 
the carotid arteriotomy closed. The animal was then 
killed with a lethal dose of euthanasia solution. In 
both acute and chronic ases, before xplantation, the 
fully anesthetized animal was killed with a lethal dose 
of euthanasia solution. The abdominal aorta and iliac 
arteries were then exposed through the left flank inci- 
sion and left in situ. The aorta containing the bifur- 
cated graft was then observed and measured, and 
findings were recorded. The aorta was then cross- 
clamped proximal to the renal arteries, transsected 
proximal to the clamp, and dissected free from adja- 
cent tissue. The iliac and femoral arteries on both 
sides were dissected free and transsected distal to the 
femoral arteriotomies. The excised specimen was 
then opened and gross observations were made. In 
chronic cases the grafts were fixed in a formalin- 
glutaraldehyde solution for histologic examination. 
These included cross sections above and at the level of 
the proximal and distal attachment systems and in the 
midportion of the graft. These were processed with 
hematoxylin and eosin for routine examination, Ma- 
son's trichrome stain to demonstrate collagen forma- 
tion, and elastin van Gieson's stain to evaluate the 
native vessels and preservation of the internal and 
external elastic lamina. 
The devices implanted consisted of seven non- 
crimped grafts and eight crimped grafts. As the study 
progressed, modifications of the device were made to 
correct problems identified uring the experiments. 
RESULTS 
All grafts (n = 15) were patent at the end of the 
procedure. Of  four animals intended for chronic 
evaluation, three had immediate postoperative hind 
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Fig. 3. Deployment sequence and technique. A, Passage of pull-wire assembly attached to 
contralateral capsule over aortic bifurcation by use of contralateral snare catheter. B, Insertion 
of entire device, while pulling contralateral pull-wire. Note that device is inserted over stiff 
ipsilateral guide wire. C, Position of bifurcated prosthesis above bifurcation, after etraction of 
capsule jacket to free contralateral prosthesis limb. D, Deployment of proximal attachment 
system and balloon inflation to secure hooks into aortic wall. E, Deployment of contralateral 
attachment system after insertion of engaging torque catheter to ensure appropriate orientation. 
Note locking ball has been advanced through ipsilateral prosthesis to release contralateral 
attachment system and maintain guiding wire through contralateral limb. F, Release and balloon 
deployment of ipsilateral attachment system, which completes deployment. Completion 
arteriogram then follows. 
limb paralysis. These three animals were evaluated by 
a veterinary neurologist, who made the clinical 
diagnosis of spinal cord ischemia. All three animals 
that had this complication were killed prematurely 
and included in the acute group. 
All seven noncrimped grafts showed minor kinks 
in areas of curvature that did not appear to be 
hemodynamically significant by angiographic evalu- 
ation. None of the eight crimped grafts had evidence 
of kinks on angiography. Areas of curvature appeared 
to be handled better by the crimped prosthesis. 
Torque control of the body and individual limbs of 
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Fig. 4. GrosS appearance after implantation. Note ab- 
sence of tears at sites of attachment system hooks. 
the device was necessary to correct twists before 
deployment in 10 of 15 implants. Of the 10 implants 
that required torque control for accurate implanta- 
tion, two showed approximately 30-degree twists 
that did not appear to affect blood flow on comple- 
tion angiography. 
One implant was entirely deployed in the aorta 
because of parallax error. This was subsequently 
avoided by the use of a posterior marker board to 
minimize the distance between the marker and the 
aorta. In this particular device, the error occurred 
because the marker (a radiopaque instrument) was 
placed in the ventral portion of the animal at a 
significant distance from the aorta. Thus any move- 
ment of the fluoroscopy equipment produced a 
significant error in the subsequently identified im- 
plantation site. Three premature deployments oc- 
curred early in the experience, which were corrected 
by attachment system lock modification. Devices 
implanted after this correction did not have deploy- 
ment before the operator's intention. Mean final 
implant position was within 2.9 _+ 1.4 mm at the 
aortic position. The contralateral nd ipsilateral ifiac 
limb were within 1.6 _ 1.1 mmand 1.5 _+ 0.8 mm, 
respectively, of the intended position. These mea- 
surements include all grafts, with the exception of the 
one that was inadvertently implanted completely in 
the aorta because of parallax error. Clearly, the final 
lilac position site was determined in large part by 
accurate deployment at the aortic site. Results are 
summarized in Table I. 
Macroscopic examination of the animals in the 
acute group revealed an i tact proximal (superior) 
anastomosis with small (< 1 cm) ecchymotic areas 
caused by hook penetration. Similar findings were 
encountered at the iliac implantation site. In no 
instance was there any hematoma or evidence of 
retroperitoneal hemorrhage. It must be kept in mind 
that the thickness of the aortic wall in these animals 
with normal vessels is less than the anticipated 
thickness of the aorta in humans. In any event, no 
longitudinal tears were evident, which could have 
occurred as a result of graft manipulation during 
distal deployment of the iliac limbs (Fig. 5). Most 
grafts had small areas of folds, mostly in the 
longitudinal dimension, because of the inability of 
the graft to expand completely within the normal- 
diameter aorta. This did not appear to affect flow, nor 
were they evident on angiography. No thrombus 
formation was seen on any of the acute specimens. 
The single animal that survived and was available 
for chronic implantation was killed at 2 weeks. 
Macroscopic examination of the superior attachment 
system disclosed formation of a glistening, thin 
membrane of neointimal tissue along the luminal 
surface of the graft, at the hook insertion sites, and 
along the anastomosis atthe junction of the graft and 
native aorta. Similar changes were noted on cross 
sections through the lilac portions of the graft. No 
tears, thrombi, or foci of calcification were noted 
within the graft or the native vessels. The distal 
segments of the right and left iliac arteries were 
inspected and did not show evidence of intimal 
disruption, tears, or thrombus formation. Micro- 
scopic examination showed that the luminal surface 
between the graft and the aortic lumen had developed 
a thin neointimal layer composed of loosely arranged 
edematous granulation tissue and mixed with vari- 
able amounts of fibrin and blood (Fig. 6). An 
identical composition of fibrin and early granulation 
tissue was also present in the layer between the graft 
and the native iliac vessel. No calcification or giant 
cell reactions were noted. Longitudinal histologic 
sections through the proximal hook insertion site, 
and the distal hook insertion site, revealed sharply 
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Fig. 5. A, Proximal anastomosis of prosthesis demonstrates neointimal layer of loose 
edematous ti sue. (Hematoxylin a d eosin stain. Original magnification x 60.) B, Elastin fibers 
of medial layer ofaorta beneath graft are compressed. No inflammation is seen within medial 
layer. (Elastin van Geison stain. Original magnification x 60.) 
delineated linear transmural disruption of the native 
aorta. These were surrounded by loose granulation 
tissue, indicative of early vessel wall repair to the 
penetrating hooklet. No acute inflammatory cells, 
abscess formation, calcification, or marked giant cell 
reaction was noted. Longitudinal sections at the 
proximal and distal inferior anastomotic sites also 
displayed the presence of early reparative r action, 
with a zone of granulation tissue and pannus 
overlying the graft and extending along the luminal 
surface of the graft. Identical histologic features, as 
those seen in the proximal sections, were seen at the 
distal anastomotic sites. These indicate a normal 
healing phase of injury, with neointimal develop- 
ment. Sections of the native aortic vessel above the 
graft and below the iliac segments of the graft show 
normal arge elastic arterial vessels without intimal or 
medial defects. No inflammation, thrombus forma- 
tion, or calcifications were seen. 
After the occurrence of paraplegia in the animals 
intended for chronic evaluation, pilot experiments 
were carried out in an attempt to preserve blood flow 
to the common mink of the internal i iac arteries. We 
anticipated that, if we could maintain flow into this 
system, the incidence of paraplegia would be reduced 
drastically. Five devices were constructed in which 
one limb was truncated at the graft bifurcation, 
leaving one long limb that was to be implanted in a 
single iliac system. Thus the graft would have a 
proximal attachment system in the aorta, similar to 
the bifurcated prosthesis; however, only one limb 
would be placed in the iliac artery, with the truncated 
limb being free in the aorta to perfuse both the 
contralatcral i iac and the internal iliac common 
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trunk. After implantation of these devices, aortogra- 
phy disclosed that the intended goal was accom- 
plished. Flow was maintained in both the contralat- 
eral iliac and internal iliac common trunk by the 
shortened contralateral limb. Nevertheless, all five 
animals awoke with hind limb paralysis. This sug- 
gests that the likely cause for paraplegia was occlusion 
of segmental lumbar arteries by the trunk of the graft, 
which may have caused spinal cord ischemia in spite 
of continued perfusion of the internal iliac system. 
DISCUSSION 
This experiment was performed to evaluate the 
acute and chronic performance of a bifurcated 
endovascular g aft designed for implantation in the 
human aortoiliac segment. The animal model chosen 
mimics in size and appearance the arterial system in 
humans. Nevertheless, this model proved not suitable 
for chronic evaluation because of its propensity to 
develop spinal cord ischemia with manifest paraple- 
gia immediately after aortic graft implantation. Pilot 
experiments suggest that this is the result of occlusion 
of segmental lumbar branches, rather than the 
internal lilac arteries. When a modified prosthesis 
with a short limb was used to maintain perfusion to 
the internal iliac system, paraplegia still occurred. In 
the single experiment available for histologic evalu- 
ation and examined at 2 weeks, the healing process 
appears imilar to that seen in surgically implanted 
prostheses. There appears to be pannus ingrowth 
across the graft artery interface. In both acute and the 
single chronic cases, there was no evidence or 
periaortic hemorrhage from the hooklets used to 
anchor the attachment system. 
The immediate results of graft implantation 
proved satisfactory. All proximal attachment systems 
were implanted predictably within 6 mm of the 
intended location. The mean was 2.5 mm, although 
with 2 SDs on each side this would add up to a 12 
mm neck necessary for 99% implantation accuracy. 
In studies done by Chuter et al.8 on the configuration 
of aneurysms, at least 80% of infrarenal abdominal 
aortic aneurysms have a 1 cm or greater proximal 
neck. One must take into account that, in this 
particular experiment, the imaging was less than 
optimal because of the size of the animals. Thus one 
can anticipate improved accuracy in humans, com- 
pared with the animal model. 
Angulation of the prosthesis, creating a kink 
caused by curvatures in the arterial system, was seen 
only in the uncrimped prosthesis. Crimping appears 
to afford the prosthesis better tolerance to curvatures 
in the system. Although none of the kinks produced 
in this animal model appeared hemodynamically 
significant, the anticipated vessel tortuosity, usually 
seen in patients with abdominal aortic aneurysms, 
would suggest that a crimped prosthesis preferable. 
Although some investigators have proposed that 
crimping of a surgically implanted prosthesis is 
unnecessary, one must take into account that when a 
prosthetic graft is implanted surgically, vessel tortu- 
osity is not an issue, because the prosthesis takes the 
straighter course regardless of the path of the actual 
arterial system. In an endovascular device, however, 
the prosthesis forced to follow the tortuosity of the 
vessel and, therefore, kink resistance in the graft will 
be necessary. Crimping appears to afford the pros- 
thesis this characteristic. 
Because vessel tortuosity can be anticipated, 
rotation of the device during implantation for ease of 
insertion will be necessary. Thus the device itself must 
tolerate torque forces applied to it during implanta- 
tion. In this animal model, the need to rotate the 
device to traverse tortuous vessels during initial 
insertion was not necessary. These maneuvers were 
applied only to avoid twists in the final implant. We 
can anticipate the need for rotation during insertion, 
and thus the device has been designed so that it will 
tolerate some degree of rotational motion. Although 
twists in a tube prosthesis are well tolerated, espe- 
cially if maintained similarly in both proximal and 
distal attachment systems, in a bifurcated evice this 
can lead to unacceptable results. Thus identifying the 
orientation of the device after initial insertion is of 
utmost importance. This particular system allows 
rotation of both the body of the graft and each 
individual limb, afforded by the design of the system. 
Radiographic opaque markers are used to identify 
twists in the body and each individual imb, thus 
decreasing the possibility of altering the relationship 
between the body and the limbs of the graft. 
Patency was confirmed in all experiments by 
completion angiography. Long-term results, how- 
ever, could not be obtained in this set of experiments 
because of the intolerance of these animals to 
segmental aortic grafting. Considering that the 
prosthesis i a Dacron prosthesis, imilar to the one 
used in surgical reconstruction of the aortoiliac 
system, one could anticipate similar performance in
the endovascular setting. Nevertheless, because of the 
difference in the attachment system and method of 
insertion, further evaluation of this aspect of this 
device will be necessary. 
The basic concept for insertion of a bifurcated 
prosthesis by endoluminal pproach was described by 
Chuter et al. 9 in 1993. The device herein described 
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uses the same basic concepts for implantation, with 
the contralateral limb of the bifurcated prosthesis 
directed by the use of  a transfemoral guide wire. The 
EVT system is fully engineered with all the needed 
features to accomplish implantation with an off-the- 
shelf catheter, and thus the technique for implanta- 
tion is different. Because of its many features, the 
complexity of the system is a potential drawback. 
The frequent need for a bifurcated prosthesis for 
endolurninal treatment of abdominal aortic aneu- 
rysms has led investigators to use alternatives to a 
bifurcated prosthesis. Recently, a report by Parodi et 
al. 1° indicated the use of an aortounilateral iliac 
endoprosthesis, with obliteration of  the contralateral 
iliac vessel. A femorofemoral graft is used to complete 
lower extremity revascularization. This approach is 
simpler. It  relies, however, on thrombosis of the iliac 
portion of the aneurysm, which may not eliminate 
completely the risk of rupture. 
Overall, endovascular ortic grafting is an attrac- 
tive option in the treatment of abdominal aortic 
aneurysms. It is likely that this technology will evolve 
into other areas of vascular grafting. Already, reports 
have appeared ocumenting the use of endovascular 
grafts in the treatment of traumatic arteriovenous 
fistulas, isolated peripheral aneurysms, and peripheral 
occlusive disease. 11-13 Long-term results of this ap- 
proach, however, must await follow-up. One must be 
concerned about he long-term performance, because 
it relates to the security of  fixation of the graft, 
growth of the native system, and, particularly in 
aneurysms, the effect of collateral circulation within 
the isolated sac. 
In conclusion, the EVT bifurcated endovascular 
graft appears to be suitable for human aortoiliac 
implantation. The proximal attachment system can 
be deployed predictably within a 12 mm segment of  
the aorta. Kinldng can be reduced by crimping of the 
prosthesis. Torque control of  the device will be 
needed, both during insertion and to correct wists, 
a maneuver that will be critical in the implantation of 
a bifurcated prosthesis. The calf is not a suitable 
model for chronic evaluation of aortoiliac grafting by 
endovascular means, because of the animal's uscepC 
tibility to spinal cord ischemia. Long-term heating of  
this prosthesis could thus not be evaluated and must 
await results of  phase I clinical trials currently in 
progress. 
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DISCUSSION 
Dr. John M. Porter (Portland, Ore.). You have 
demonstrated that you have mastered a series of technical 
problems and have been able to implant an endoluminal 
bifurcated aneurysm graft satisfactorily into a small number 
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of calves. For practical purposes, there is no follow-up 
information beyond the acute implantation. I note that Dr. 
Timothy Chuter has implanted a competing bifurcated 
endoluminal prosthesis in patients and has presented a
preliminary report of this in Lancet. I have two sets of 
concerns about the intermediate-term future of endolumi- 
hal aneurysm grafting in patients, the first technical and the 
second philosophical. 
My technical concerns are centered about he behavior 
of the graft itself. We all remember the days of the 
McGovern sutureless aortic valve prosthesis. As I recall, this 
prosthesis generally gave satisfactory early results, but there 
was a long-term high incidence of aortic valve insufficiency, 
with delayed leaks where the metallic implantation arms 
engaged the aortic anulus. Are we going to see a similar 
phenomenon here? I would like to know more about the 
Dacron used in the graft itself. We know that thin-walled 
Dacron did not perform satisfactorily inclinical practice. Is 
the thickness of the Dacron used here comparable to that 
currently used in clinical practice? I note that there are at 
least several reports in abstract form of aneurysm rupture in 
patients with an endoluminal ortic graft in place. Can you 
provide additional information. 
I would like to know how many patients with 
aneurysms will be candidates for endoluminal grafting. 
Presently, less than 10% of our patients have the combi- 
nation of the requisite infrarenal aortic neck and reasonably 
patent iliac arteries through which to pass the prosthesis. I 
understand that EVT screening is 20 to 30:1 to find 
eligible patients with abdominal aortic aneurysms. It seems 
to me that the patients who will be best served by this graft 
are those with small aneurysms and long aneurysmal necks, 
in a number of whom treatment could reasonably be 
deferred without compromise. Extending this expensive 
health care to patients with an indication for aneurysm 
below the surgery threshold can only serve to increase 
health-care costs. 
My second reservation i this area is more philosophi- 
cal and centers on an attempt to define clearly just what we 
are trying to accomplish with endovascular g afting. Many 
academic enters with significant experience are currently 
reporting aortic aneurysm operative mortality rates in the 
range of 1% to 3%. No one claims endoluminal grafting to 
have lower mortality or morbidity rates than conventional 
surgery. The costs are certainly comparable, especially 
considering the diagnosis-related groups for aneurysm 
grafting. The only real benefit hat I can detect is the speed 
of recovery from the procedure. Patients who undergo 
abdominal aortic aneurysm surgery require 2 to 3 months 
for return to normal activity. I understand most people 
with endoluminal grafts have substantial recovery by 2 to 
4 weeks or less. Thus there is a clear 1- to 2-month recovery 
benefit in favor of the endoluminal aneurysm grafting. 
However, 90% plus of our patients with aneurysms are 
retired, and whether they spend 3 weeks or 3 months 
recovering seems ultimately of little significance. Thus I am 
still trying to understand the persuasive benefits of this 
form of therapy for patients with infrarenal abdominal 
aortic aneurysms. I suppose we can do it, but is there any 
reason to? 
Dr. William J. Quifiones-Baldrich. With regard to 
the graft itself, this is the same Dacron prosthesis that is 
used for surgical implantation. It is made by one of the 
manufacturers that makes tandard Dacron aortic prosthe- 
ses, so there is no difference in the thickness. 
There are some efforts to look at prostheses that are 
somewhat thinner so that we can reduce the size of the 
deployment catheter. There is a difference when you have 
an aneurysm that is intact and thrombosis around the graft. 
I have the suspicion that we may be able to use prostheses 
that are somewhat thinner and still get a secure repair. 
With regard to the attachment system, that is one of the 
big questions about endovascular neurysm repair or any of 
the endovascular g aft implantations. Specifically for aneu- 
rysms, we are obviously concerned that there might be 
some increase in the size of the neck of the aneurysm that 
may then lead to a leak or migration of the graft and, 
therefore, not protect he patient from rupture. The only 
way to answer that question is to do adequate clinical 
studies with careful follow-up, because I do not think that 
any animal model would be suitable to answer this 
question. 
As far as the question of aneurysm rupture in patients 
who have undergone endovascular neurysm repair, at the 
University of California, Los Angeles, we are following 18 
patients who have undergone endovascular aneurysm 
repair with either a tube or bifurcated prosthesis, and these 
patients undergo computed tomographic s anning every 3 
months; so far there has been no growth in the aneurysms. 
A few aneurysms have actually decreased in size. There is 
one patient who continues to be monitored who has 
demonstrable flow between native arteries within the 
aneurysm sack. This aneurysm has not thrombosed com- 
pletely. This patient is of great interest and thus we monitor 
him closely. Thus conditions in 17 of the 18 patients appear 
to be stable. These are not small aneurysms. These are 
aneurysms that were 6, 7, and 8 cm in size. 
With regard to the question why do it, I anticipate that 
this intervention is likely to decrease morbidity rates and 
maybe ven mortality rates of aneurysm repair. Whereas it 
is true that there are reports in the literature citing 2% and 
3% mortality rates for conventional neurysm repair, that 
may not be true across the country. I suspect that the actual 
mortality rate of aneurysm repair by conventional means is 
a bit higher than that. 
In our experience with endovascular neurysm repair, 
all patients have left the hospital within 48 hours. Only a 
few of the patients have been in the intensive care unit, 
mainly for heart monitoring. Most have gone back to the 
floor, and the recovery is actually not as long as 2 to 4 
weeks. I believe it is more in the order of about 1 week or 
so. It is no different from the recovery of a conventional 
hernia operation, in which you have an incision in the soft 
tissues in the groin. 
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Even though most of the patients who will undergo 
this procedure are going to be in the retired population, I 
suspect they would like to go back to their normal activities 
as soon as possible and, therefore, I think that will be 
perhaps the greatest benefit. 
Dr. Calvin B. Ernst (Detroit, Mich.). You mentioned 
something about graft crimping and I think that is 
something that should be evaluated further. If you place a 
crimped graft in a normal iliac artery of a calf where the 
graft actually is gripped by the artery, the graft will remain 
relatively stationary. On the other hand, I have concern that 
putting a crimped graft in an aneurysmal sac with limited 
external support may lead to ultimate elongation of the 
graft and distal kinking. 
It seems to me that it would be better to use a 
noncrimped graft or have a deployment system whereby a
crimped graft can be adjusted and stretched to remove the 
crimping. This would also provide more slack and therefore 
greater latitude in the distal deployment system for 
adjustment purposes. 
Dr. Quifiones-Baldrich. There is a fundamental 
difference between the surgical implantation and the 
endovascular implantation of an aortic graft. When we 
implant a graft surgically, the graft will take the straightest 
route between two points. It does not have to negotiate any 
curves. When we implant he graft endovascularly we are 
asking the graft to follow the course of the vessel, and I 
think that fundamental difference will make kinking a 
bigger problem for the endovascular p osthesis. 
One of the ideas that is being considered is the 
possibility of having a telescoping system whereby ou can 
adjust he length of the distal imbs after the proximal graft 
has been deployed. This may accomplish what we want: a 
patent graft without any kinks. 
When you place a graft endovascularly, it has to have 
some type of kink resistance. Whether you accomplish that 
as some have done by the placement ofstents in the area or 
do it by crimping, I am not sure which is better. In this 
particular experiment i appears that crimping did afford 
the graft kink resistance. 
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